SOURCE: The Small Cap Investor

Zacks Small Cap Research Library at

March 10, 2011 10:34 ET

Zacks Investment Research Joins for Expanded Small Cap Research Distribution

ORLANDO, FL--(Marketwire - March 10, 2011) - The Small Cap Investor ("TSCI") today announced Zacks Small Cap Research, a division of Zacks Investment Research, has begun distributing its independent small cap equity reports at Zacks Small Cap Research is now available for investors to purchase as individual reports at the Zacks research library on the site. TSCI Premium Members also have the option to subscribe to an annual subscription for unlimited access to all of Zacks Small Cap Research for a year.

During the next few days, TSCI will populate the Zacks research library ( with every Zacks report from 2010 and 2011, and will post new reports as they are released. Zacks reports already available on the site include: CryoPort, Inc. (OTCQB: CYRX), Access Pharma, Trinity Biotech, Acorn Energy, Neurocrine Bio, Depomed, Applied DNA Sciences, Aastrom Bio, Pozen, Chembio Diagnostics, inTEST, Group TMM and Trius Therapeutics.

Individual and professional investors are invited to review the website and register for a FREE membership. To set up a personal member profile, please visit:

Stocks with research available includes a range of companies across multiple industries with stocks trading on the NYSE, AMEX, NASDAQ and the OTC Markets. International exchanges include the Canadian exchanges (TSX, TSX-V and CNQ), as well as London's AIM & LSE, Germany's Frankfurt exchange and Australia's ASX.

About The Small Cap Investor

The Small Cap Investor is a financial media company providing the Internet's most efficient platform for the dissemination of equity research, multimedia, news, opinion and commentary as it relates to the small cap markets. With over 1,800 independent equity reports available, is the web's leading comprehensive distribution service designed to act as a single, consolidated meeting location for small cap equity research professionals and the investors who seek that research. It is designed for both individual and professional investors and offers free membership, as well as premium services, including access to institutional quality research reports from leading independent equity research firms.

About Zacks
Zacks Small Cap Research is a property of Zacks Investment Research, Inc., which was formed in 1978 by Len Zacks. The company continually processes stock reports issued by 3,000 analysts from 150 brokerage firms. It monitors more than 200,000 earnings estimates, looking for changes.

Then, when changes are discovered, they're applied to help assign more than 4,400 stocks into five Zacks Rank categories: #1 Strong Buy, #2 Buy, #3 Hold, #4 Sell, and #5 Strong Sell. This proprietary stock-picking system continues to outperform the market by a nearly 3-to-1 margin.

The Small Cap Investor -- In The World of Investments, Knowledge is Power™

Contact Information